Success Metrics

Clinical Success Rate
92.9%

Based on 13 completed trials

Completion Rate
93%(13/14)
Active Trials
1(5%)
Results Posted
8%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
2
10%
Ph phase_3
1
5%
Ph not_applicable
2
10%
Ph phase_1
3
14%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(1)
Completed(13)
Terminated(3)
Other(4)

Detailed Status

Completed13
unknown4
Withdrawn2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
92.9%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (37.5%)
Phase 22 (25.0%)
Phase 31 (12.5%)
N/A2 (25.0%)

Trials by Status

unknown419%
withdrawn210%
terminated15%
completed1362%
recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT00898313

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

Recruiting
NCT01336933Phase 2

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Completed
NCT00897936

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Completed
NCT00897273

Oral HPV Infection in Young Men

Completed
NCT00471653

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Terminated
NCT00899028

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Completed
NCT00433485Phase 1

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Completed
NCT00003863

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
NCT00049010Not Applicable

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Completed
NCT01169376

Biomarkers in Young Patients With Neuroblastoma

Completed
NCT00053235

Research Study in Patients With Advanced Ovarian Epithelial Cancer

Withdrawn
NCT01480518

Biomarkers in Tissue Samples From Patients With Ewing Sarcoma

Completed
NCT00003096

Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors

Completed
NCT00967954Not Applicable

Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer

Unknown
NCT00717587Phase 2

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Unknown
NCT00516347

Studying Genes for Barrett's Esophagus in Brothers and Sisters

Unknown
NCT00070278Phase 3

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Unknown
NCT00897091

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Completed
NCT00899002

Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer

Withdrawn
NCT00389922Phase 1

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Completed

Drug Details

Intervention Type
GENETIC
Total Trials
21